215 related articles for article (PubMed ID: 35085664)
1. Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis.
Bandyopadhyay M; Morelli AE; Balmert SC; Ward NL; Erdos G; Sumpter TL; Korkmaz E; Kaplan DH; Oberbarnscheidt MH; Tkacheva O; Shufesky WJ; Falo LD; Larregina AT
J Allergy Clin Immunol; 2022 Jul; 150(1):114-130. PubMed ID: 35085664
[TBL] [Abstract][Full Text] [Related]
2. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
[TBL] [Abstract][Full Text] [Related]
3. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
5. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin-1 Receptor Signaling Is Required for Efficient Ca
Morelli AE; Sumpter TL; Rojas-Canales DM; Bandyopadhyay M; Chen Z; Tkacheva O; Shufesky WJ; Wallace CT; Watkins SC; Berger A; Paige CJ; Falo LD; Larregina AT
Cell Rep; 2020 Mar; 30(10):3448-3465.e8. PubMed ID: 32160549
[TBL] [Abstract][Full Text] [Related]
7. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.
Janelsins BM; Sumpter TL; Tkacheva OA; Rojas-Canales DM; Erdos G; Mathers AR; Shufesky WJ; Storkus WJ; Falo LD; Morelli AE; Larregina AT
Blood; 2013 Apr; 121(15):2923-33. PubMed ID: 23365459
[TBL] [Abstract][Full Text] [Related]
9. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
[TBL] [Abstract][Full Text] [Related]
10. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
[TBL] [Abstract][Full Text] [Related]
11. In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses.
Mathers AR; Tckacheva OA; Janelsins BM; Shufesky WJ; Morelli AE; Larregina AT
J Immunol; 2007 Jun; 178(11):7006-17. PubMed ID: 17513750
[TBL] [Abstract][Full Text] [Related]
12. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.
Janelsins BM; Mathers AR; Tkacheva OA; Erdos G; Shufesky WJ; Morelli AE; Larregina AT
Blood; 2009 Mar; 113(13):3017-26. PubMed ID: 18987361
[TBL] [Abstract][Full Text] [Related]
14. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin 1 Receptor Antagonists for Pruritus.
Alam M; Buddenkotte J; Ahmad F; Steinhoff M
Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
[TBL] [Abstract][Full Text] [Related]
17. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
18. A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes.
Mai QN; Shenoy P; Quach T; Retamal JS; Gondin AB; Yeatman HR; Aurelio L; Conner JW; Poole DP; Canals M; Nowell CJ; Graham B; Davis TP; Briddon SJ; Hill SJ; Porter CJH; Bunnett NW; Halls ML; Veldhuis NA
J Biol Chem; 2021; 296():100345. PubMed ID: 33515548
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis.
Scholzen TE; Steinhoff M; Bonaccorsi P; Klein R; Amadesi S; Geppetti P; Lu B; Gerard NP; Olerud JE; Luger TA; Bunnett NW; Grady EF; Armstrong CA; Ansel JC
J Immunol; 2001 Jan; 166(2):1285-91. PubMed ID: 11145711
[TBL] [Abstract][Full Text] [Related]
20. Allergic contact dermatitis.
Gober MD; Gaspari AA
Curr Dir Autoimmun; 2008; 10():1-26. PubMed ID: 18460878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
